drugset / Trial / NCT01475071

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses

NCT01475071

Phase 3 Completed 100 enrolled Galderma R&D
RandomizedSingle-groupSingle-blindTreatment

Summary

The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy with Aktilite™ lamp in subjects with mild actinic keratoses (intra-individual comparison).

Timeline

Start
2012-03
Primary completion
2012-11
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject methyl aminolevulinate Small molecule 160 unknown

Indications